SLK expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.885380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.784230E-01
Normal-vs-Stage2
1.653030E-01
Normal-vs-Stage3
4.011000E-01
Normal-vs-Stage4
1.097430E-01
Stage1-vs-Stage2
9.217200E-01
Stage1-vs-Stage3
7.941600E-01
Stage1-vs-Stage4
5.778000E-01
Stage2-vs-Stage3
7.849000E-01
Stage2-vs-Stage4
4.328200E-01
Stage3-vs-Stage4
5.176000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.014000E-01
Normal-vs-AfricanAmerican
2.650000E-01
Normal-vs-Asian
2.394600E-01
Caucasian-vs-AfricanAmerican
4.438400E-01
Caucasian-vs-Asian
9.624800E-01
AfricanAmerican-vs-Asian
5.724800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.786580E-01
Normal-vs-Female
2.118800E-01
Male-vs-Female
4.011800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.196000E-01
Normal-vs-Age(41-60Yrs)
1.236820E-01
Normal-vs-Age(61-80Yrs)
2.324400E-01
Normal-vs-Age(81-100Yrs)
2.350800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.158400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.084600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.479000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.163500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.018400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.015600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.386400E-01
Normal-vs-Daily Drinker
2.803800E-01
Normal-vs-Weekly Drinker
3.427000E-01
Normal-vs-Occasional Drinker
1.052820E-01
Normal-vs-Social Drinker
2.441000E-01
Non Drinker-vs-Daily Drinker
8.449000E-01
Non Drinker-vs-Weekly Drinker
9.299800E-01
Non Drinker-vs-Occasional Drinker
2.003200E-01
Non Drinker-vs-Social Drinker
7.133400E-01
Daily Drinker-vs-Weekly Drinker
9.453400E-01
Daily Drinker-vs-Occasional Drinker
3.476600E-01
Daily Drinker-vs-Social Drinker
6.291400E-01
Weekly Drinker-vs-Occasional Drinker
3.790400E-01
Weekly Drinker-vs-Social Drinker
7.201600E-01
Occasional Drinker-vs-Social Drinker
1.440440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.973640E-01
Normal-vs-Grade 2
2.157900E-02
Normal-vs-Grade 3
1.022270E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.683150E-03
Grade 1-vs-Grade 3
5.759600E-04
Grade 1-vs-Grade 4
1.973640E-01
Grade 2-vs-Grade 3
4.090200E-01
Grade 2-vs-Grade 4
2.157900E-02
Grade 3-vs-Grade 4
1.022270E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.429400E-01
Normal-vs-NonDiabetic
1.968160E-01
Diabetic-vs-NonDiabetic
5.056800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.107780E-01
Normal-vs-NoPancreatitis
2.152200E-01
Pancreatitis-vs-NoPancreatitis
4.707800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.932020E-01
Normal-vs-N1
1.795590E-01
N0-vs-N1
9.891200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.282200E-02
Normal-vs-TP53-NonMutant
3.509600E-01
TP53-Mutant-vs-TP53-NonMutant
4.597000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
